INS and synucleinopathy: While there are contrasting data from worm and fly models of synucleinopathy showing that reduced insulin signaling is neuroprotective [106], it is possible that different PD models may reflect different stages of synucleinopathy that may or may not match those of the PD patients who participated in the clinical trials.